Design Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 05/13/2025 | 6.53 M | $25.19 M | 0.00% | 11.50% |
LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 4.22 M | $16.28 M | 0.00% | 7.43% |
BLACKROCK, INC. | 05/02/2025 | 2.48 M | $9.57 M | -3.86% | 4.37% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 1.95 M | $7.54 M | 0.00% | 3.44% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 1.82 M | $7.02 M | -2.09% | 3.20% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 1.74 M | $6.73 M | 0.00% | 3.07% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.68 M | $6.49 M | 13.50% | 2.96% |
ALMITAS CAPITAL LLC | 05/15/2025 | 1.45 M | $5.61 M | 9.76% | 2.56% |
VANGUARD GROUP INC | 05/09/2025 | 1.43 M | $5.51 M | -0.23% | 2.52% |
CITADEL ADVISORS LLC | 05/15/2025 | 963.46 K | $3.72 M | 0.49% | 1.70% |
FMR LLC | 05/12/2025 | 948.05 K | $3.66 M | -0.40% | 1.67% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 913.40 K | $3.53 M | 17.69% | 1.61% |
KYNAM CAPITAL MANAGEMENT, LP | 05/15/2025 | 904.02 K | $3.49 M | 100.00% | 1.59% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 775.50 K | $2.99 M | 1.82% | 1.37% |
STATE STREET CORP | 05/15/2025 | 714.07 K | $2.76 M | -1.28% | 1.26% |
WOODLINE PARTNERS LP | 05/15/2025 | 645.69 K | $2.49 M | 100.00% | 1.14% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 630.95 K | $2.43 M | 11.16% | 1.11% |
BIOIMPACT CAPITAL LLC | 05/15/2025 | 562.94 K | $2.17 M | 0.61% | 0.99% |
D. E. SHAW & CO., INC. | 05/15/2025 | 395.25 K | $1.53 M | -22.85% | 0.70% |
NORTHERN TRUST CORP | 05/13/2025 | 373.65 K | $1.44 M | -3.73% | 0.66% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 288.60 K | $1.11 M | 34.07% | 0.51% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 266.02 K | $1.03 M | -10.47% | 0.47% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 265.00 K | $1.02 M | 4.54% | 0.47% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 258.38 K | $997.33 K | -2.38% | 0.46% |
MORGAN STANLEY | 05/15/2025 | 247.88 K | $956.81 K | -28.40% | 0.44% |
05/12/2025 | 147.23 K | $568.30 K | 100.00% | 0.26% | |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 146.70 K | $566.26 K | -37.28% | 0.26% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 141.52 K | $546.26 K | 100.00% | 0.25% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 128.75 K | $496.96 K | -36.87% | 0.23% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 113.80 K | $439.27 K | -11.37% | 0.20% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 95.35 K | $368.04 K | 0.00% | 0.17% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 87.99 K | $339.63 K | 100.00% | 0.16% |
BARCLAYS PLC | 05/15/2025 | 84.01 K | $324.00 K | -18.89% | 0.15% |
GSA CAPITAL PARTNERS LLP | 05/08/2025 | 72.15 K | $278.00 K | -39.03% | 0.13% |
LYNX1 CAPITAL MANAGEMENT LP | 05/15/2025 | 65.95 K | $254.58 K | 100.00% | 0.12% |
PALUMBO WEALTH MANAGEMENT LLC | 04/22/2025 | 58.28 K | $224.95 K | 6.55% | 0.10% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 56.41 K | $217.72 K | 0.16% | 0.10% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 52.87 K | $204.09 K | 31.23% | 0.09% |
RHUMBLINE ADVISERS | 05/29/2025 | 46.37 K | $178.98 K | -12.40% | 0.08% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 44.42 K | $171.44 K | 13.55% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 43.22 K | $166.84 K | 15.84% | 0.08% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 42.09 K | $162.47 K | 0.00% | 0.07% |
ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 36.92 K | $142.50 K | -34.80% | 0.07% |
UBS GROUP AG | 05/13/2025 | 32.82 K | $126.68 K | -50.71% | 0.06% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 31.74 K | $122.52 K | 6.31% | 0.06% |
DEUTSCHE BANK AG\ | 05/09/2025 | 28.13 K | $108.58 K | 0.12% | 0.05% |
CI PRIVATE WEALTH, LLC | 05/14/2025 | 26.97 K | $104.09 K | 0.00% | 0.05% |
CITIGROUP INC | 05/12/2025 | 22.88 K | $88.31 K | -6.52% | 0.04% |
STRS OHIO | 05/28/2025 | 22.60 K | $87.24 K | -30.67% | 0.04% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 22.17 K | $85.56 K | -36.96% | 0.04% |
Design Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 205 institutional investors and hedge funds held shares of Design Therapeutics, Inc.. The most heavily invested institutionals were:
SR ONE CAPITAL MANAGEMENT, LP: 6.53 M
Logos Global Management LP: 4.22 M
BlackRock, Inc.: 2.48 M
Frazier Life Sciences Management, L.P.: 1.95 M
Point72 Asset Management, L.P.: 1.82 M
BAKER BROS. ADVISORS LP: 1.74 M
60.71% of Design Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.00 M shares in the last 24 months. This purchase volume represents approximately $169.63 M in transactions.